Home Applications 216873 Application 216873
Type NDA
Sponsor GLAXOSMITHKLINE Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 OJJAARA MOMELOTINIB DIHYDROCHLORIDE TABLET;ORAL EQ 100MG BASE Yes No 002 OJJAARA MOMELOTINIB DIHYDROCHLORIDE TABLET;ORAL EQ 150MG BASE Yes No 003 OJJAARA MOMELOTINIB DIHYDROCHLORIDE TABLET;ORAL EQ 200MG BASE Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 3 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N216873-001 OJJAARA MOMELOTINIB DIHYDROCHLORIDE EQ 100MG BASE TABLET / ORAL RLD 2023-09-15 N216873-002 OJJAARA MOMELOTINIB DIHYDROCHLORIDE EQ 150MG BASE TABLET / ORAL RLD 2023-09-15 N216873-003 OJJAARA MOMELOTINIB DIHYDROCHLORIDE EQ 200MG BASE TABLET / ORAL RLD, RS 2023-09-15
Orange Book patents# Current patent rows page 1 of 1 · 15 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N216873-001 8486941 2035-01-03 U-1201 Drug substance, Drug product 2023-10-04 N216873-001 9809559 2035-06-11 U-1201 2023-10-04 N216873-001 RE48285 2035-06-11 U-1201 Drug substance, Drug product 2023-10-04 N216873-001 12576089 2039-08-21 U-4441 2026-03-27 N216873-001 11963962 2040-12-02 U-3928 2024-05-21 N216873-002 8486941 2035-01-03 U-1201 Drug substance, Drug product 2023-10-04 N216873-002 9809559 2035-06-11 U-1201 2023-10-04 N216873-002 RE48285 2035-06-11 U-1201 Drug substance, Drug product 2023-10-04 N216873-002 12576089 2039-08-21 U-4441 2026-03-27 N216873-002 11963962 2040-12-02 U-3928 2024-05-21 N216873-003 8486941 2035-01-03 U-1201 Drug substance, Drug product 2023-10-04 N216873-003 9809559 2035-06-11 U-1201 2023-10-04 N216873-003 RE48285 2035-06-11 U-1201 Drug substance, Drug product 2023-10-04 N216873-003 12576089 2039-08-21 U-4441 2026-03-27 N216873-003 11963962 2040-12-02 U-3928 2024-05-21
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 6 matching rows.
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 60 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N216873-001 OJJAARA EQ 100MG BASE TABLET / ORAL RLD 2023-09-15 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N216873-002 OJJAARA EQ 150MG BASE TABLET / ORAL RLD 2023-09-15 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N216873-003 OJJAARA EQ 200MG BASE TABLET / ORAL RLD, RS 2023-09-15 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N216873-001 OJJAARA EQ 100MG BASE TABLET / ORAL RLD 2023-09-15 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N216873-002 OJJAARA EQ 150MG BASE TABLET / ORAL RLD 2023-09-15 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N216873-003 OJJAARA EQ 200MG BASE TABLET / ORAL RLD, RS 2023-09-15 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N216873-001 OJJAARA EQ 100MG BASE TABLET / ORAL RLD 2023-09-15 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N216873-002 OJJAARA EQ 150MG BASE TABLET / ORAL RLD 2023-09-15 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N216873-003 OJJAARA EQ 200MG BASE TABLET / ORAL RLD, RS 2023-09-15 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N216873-001 OJJAARA EQ 100MG BASE TABLET / ORAL RLD 2023-09-15 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N216873-002 OJJAARA EQ 150MG BASE TABLET / ORAL RLD 2023-09-15 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N216873-003 OJJAARA EQ 200MG BASE TABLET / ORAL RLD, RS 2023-09-15 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N216873-001 OJJAARA EQ 100MG BASE TABLET / ORAL RLD 2023-09-15 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N216873-002 OJJAARA EQ 150MG BASE TABLET / ORAL RLD 2023-09-15 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N216873-003 OJJAARA EQ 200MG BASE TABLET / ORAL RLD, RS 2023-09-15 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N216873-001 OJJAARA EQ 100MG BASE TABLET / ORAL RLD 2023-09-15 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N216873-002 OJJAARA EQ 150MG BASE TABLET / ORAL RLD 2023-09-15 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N216873-003 OJJAARA EQ 200MG BASE TABLET / ORAL RLD, RS 2023-09-15 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N216873-001 OJJAARA EQ 100MG BASE TABLET / ORAL RLD 2023-09-15 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N216873-002 OJJAARA EQ 150MG BASE TABLET / ORAL RLD 2023-09-15 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N216873-003 OJJAARA EQ 200MG BASE TABLET / ORAL RLD, RS 2023-09-15 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N216873-001 OJJAARA EQ 100MG BASE TABLET / ORAL RLD 2023-09-15 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N216873-002 OJJAARA EQ 150MG BASE TABLET / ORAL RLD 2023-09-15 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N216873-003 OJJAARA EQ 200MG BASE TABLET / ORAL RLD, RS 2023-09-15 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N216873-001 OJJAARA EQ 100MG BASE TABLET / ORAL RLD 2023-09-15 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N216873-002 OJJAARA EQ 150MG BASE TABLET / ORAL RLD 2023-09-15 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N216873-003 OJJAARA EQ 200MG BASE TABLET / ORAL RLD, RS 2023-09-15 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N216873-001 OJJAARA EQ 100MG BASE TABLET / ORAL RLD 2023-09-15 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N216873-002 OJJAARA EQ 150MG BASE TABLET / ORAL RLD 2023-09-15 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N216873-003 OJJAARA EQ 200MG BASE TABLET / ORAL RLD, RS 2023-09-15 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N216873-001 OJJAARA EQ 100MG BASE TABLET / ORAL RLD 2023-09-15 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N216873-002 OJJAARA EQ 150MG BASE TABLET / ORAL RLD 2023-09-15 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N216873-003 OJJAARA EQ 200MG BASE TABLET / ORAL RLD, RS 2023-09-15 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N216873-001 OJJAARA EQ 100MG BASE TABLET / ORAL RLD 2023-09-15 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N216873-002 OJJAARA EQ 150MG BASE TABLET / ORAL RLD 2023-09-15 301d65b070ca…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N216873-003 OJJAARA EQ 200MG BASE TABLET / ORAL RLD, RS 2023-09-15 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N216873-001 OJJAARA EQ 100MG BASE TABLET / ORAL RLD 2023-09-15 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N216873-002 OJJAARA EQ 150MG BASE TABLET / ORAL RLD 2023-09-15 1e350fbaab3a…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N216873-003 OJJAARA EQ 200MG BASE TABLET / ORAL RLD, RS 2023-09-15 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N216873-001 OJJAARA EQ 100MG BASE TABLET / ORAL RLD 2023-09-15 8072bd15b7f6…
Observed Orange Book patent history# Patent history page 1 of 6 · 225 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N216873-001 8486941 2030-01-03 U-1201 Drug substance, Drug product 2023-10-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N216873-001 9809559 2035-06-11 U-1201 2023-10-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N216873-001 RE48285 2035-06-11 U-1201 Drug substance, Drug product 2023-10-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N216873-001 11963962 2040-12-02 U-3928 2024-05-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N216873-002 8486941 2030-01-03 U-1201 Drug substance, Drug product 2023-10-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N216873-002 9809559 2035-06-11 U-1201 2023-10-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N216873-002 RE48285 2035-06-11 U-1201 Drug substance, Drug product 2023-10-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N216873-002 11963962 2040-12-02 U-3928 2024-05-21 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N216873-003 8486941 2030-01-03 U-1201 Drug substance, Drug product 2023-10-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N216873-003 9809559 2035-06-11 U-1201 2023-10-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N216873-003 RE48285 2035-06-11 U-1201 Drug substance, Drug product 2023-10-04 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N216873-003 11963962 2040-12-02 U-3928 2024-05-21 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N216873-001 8486941 2030-01-03 U-1201 Drug substance, Drug product 2023-10-04 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N216873-001 9809559 2035-06-11 U-1201 2023-10-04 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N216873-001 RE48285 2035-06-11 U-1201 Drug substance, Drug product 2023-10-04 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N216873-001 11963962 2040-12-02 U-3928 2024-05-21 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N216873-002 8486941 2030-01-03 U-1201 Drug substance, Drug product 2023-10-04 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N216873-002 9809559 2035-06-11 U-1201 2023-10-04 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N216873-002 RE48285 2035-06-11 U-1201 Drug substance, Drug product 2023-10-04 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N216873-002 11963962 2040-12-02 U-3928 2024-05-21 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N216873-003 8486941 2030-01-03 U-1201 Drug substance, Drug product 2023-10-04 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N216873-003 9809559 2035-06-11 U-1201 2023-10-04 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N216873-003 RE48285 2035-06-11 U-1201 Drug substance, Drug product 2023-10-04 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N216873-003 11963962 2040-12-02 U-3928 2024-05-21 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N216873-001 8486941 2030-01-03 U-1201 Drug substance, Drug product 2023-10-04 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N216873-001 9809559 2035-06-11 U-1201 2023-10-04 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N216873-001 RE48285 2035-06-11 U-1201 Drug substance, Drug product 2023-10-04 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N216873-001 11963962 2040-12-02 U-3928 2024-05-21 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N216873-002 8486941 2030-01-03 U-1201 Drug substance, Drug product 2023-10-04 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N216873-002 9809559 2035-06-11 U-1201 2023-10-04 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N216873-002 RE48285 2035-06-11 U-1201 Drug substance, Drug product 2023-10-04 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N216873-002 11963962 2040-12-02 U-3928 2024-05-21 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N216873-003 8486941 2030-01-03 U-1201 Drug substance, Drug product 2023-10-04 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N216873-003 9809559 2035-06-11 U-1201 2023-10-04 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N216873-003 RE48285 2035-06-11 U-1201 Drug substance, Drug product 2023-10-04 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N216873-003 11963962 2040-12-02 U-3928 2024-05-21 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N216873-001 8486941 2030-01-03 U-1201 Drug substance, Drug product 2023-10-04 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N216873-001 9809559 2035-06-11 U-1201 2023-10-04 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N216873-001 RE48285 2035-06-11 U-1201 Drug substance, Drug product 2023-10-04 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N216873-001 11963962 2040-12-02 U-3928 2024-05-21 fd3edfee7708…
Observed Orange Book exclusivity history# Exclusivity history page 1 of 3 · 120 observed states.
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Ojjaara MOMELOTINIB GlaxoSmithKline LLC 4a672fd1-eb7b-4aa9-9b23-845e4b5dc400 2026-07-20 Warnings, Adverse reactions Exact identifier application applno (NDA): 216873 application number: NDA216873
Documents# Document, Submission type, Date table Document Submission type Date 85487 SUPPL 2026-03-24 85486 SUPPL 2026-03-24 85434 SUPPL 2026-03-20 85433 SUPPL 2026-03-20 82029 SUPPL 2025-04-28 82000 SUPPL 2025-04-25 75787 ORIG 2023-10-17 75502 ORIG 2023-09-18 75499 ORIG 2023-09-18